394 related articles for article (PubMed ID: 28917532)
1. Effects of tumor microenvironments on targeted delivery of glycol chitosan nanoparticles.
Yhee JY; Jeon S; Yoon HY; Shim MK; Ko H; Min J; Na JH; Chang H; Han H; Kim JH; Suh M; Lee H; Park JH; Kim K; Kwon IC
J Control Release; 2017 Dec; 267():223-231. PubMed ID: 28917532
[TBL] [Abstract][Full Text] [Related]
2. Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency.
Na JH; Lee SY; Lee S; Koo H; Min KH; Jeong SY; Yuk SH; Kim K; Kwon IC
J Control Release; 2012 Oct; 163(1):2-9. PubMed ID: 22846988
[TBL] [Abstract][Full Text] [Related]
3. The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts.
Yhee JY; Yoon HY; Kim H; Jeon S; Hergert P; Im J; Panyam J; Kim K; Nho RS
Int J Nanomedicine; 2017; 12():6089-6105. PubMed ID: 28860768
[TBL] [Abstract][Full Text] [Related]
4. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models.
Na JH; Koo H; Lee S; Min KH; Park K; Yoo H; Lee SH; Park JH; Kwon IC; Jeong SY; Kim K
Biomaterials; 2011 Aug; 32(22):5252-61. PubMed ID: 21513975
[TBL] [Abstract][Full Text] [Related]
5. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix remodeling in vivo for enhancing tumor-targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound.
Lee S; Han H; Koo H; Na JH; Yoon HY; Lee KE; Lee H; Kim H; Kwon IC; Kim K
J Control Release; 2017 Oct; 263():68-78. PubMed ID: 28257990
[TBL] [Abstract][Full Text] [Related]
7. Precise Targeting of Liver Tumor Using Glycol Chitosan Nanoparticles: Mechanisms, Key Factors, and Their Implications.
Na JH; Koo H; Lee S; Han SJ; Lee KE; Kim S; Lee H; Lee S; Choi K; Kwon IC; Kim K
Mol Pharm; 2016 Nov; 13(11):3700-3711. PubMed ID: 27654060
[TBL] [Abstract][Full Text] [Related]
8. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
[TBL] [Abstract][Full Text] [Related]
9. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
10. Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues.
Kim JH; Bae SM; Na MH; Shin H; Yang YJ; Min KH; Choi KY; Kim K; Park RW; Kwon IC; Lee BH; Hoffman AS; Kim IS
J Control Release; 2012 Feb; 157(3):493-9. PubMed ID: 21945679
[TBL] [Abstract][Full Text] [Related]
11. Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy.
Bisht S; Maitra A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):415-25. PubMed ID: 20049807
[TBL] [Abstract][Full Text] [Related]
12. Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models.
Jeon S; Jun E; Chang H; Yhee JY; Koh EY; Kim Y; Jung JY; Jeong EJ; Lee JW; Shim MK; Yoon HY; Chang S; Kim K; Kim SC
J Control Release; 2022 Nov; 351():37-49. PubMed ID: 36089170
[TBL] [Abstract][Full Text] [Related]
13. Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice.
Oh IH; Min HS; Li L; Tran TH; Lee YK; Kwon IC; Choi K; Kim K; Huh KM
Biomaterials; 2013 Sep; 34(27):6454-63. PubMed ID: 23755832
[TBL] [Abstract][Full Text] [Related]
14. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.
Yhee JY; Song S; Lee SJ; Park SG; Kim KS; Kim MG; Son S; Koo H; Kwon IC; Jeong JH; Jeong SY; Kim SH; Kim K
J Control Release; 2015 Jan; 198():1-9. PubMed ID: 25481438
[TBL] [Abstract][Full Text] [Related]
15. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
Tian X; Yin H; Zhang S; Luo Y; Xu K; Ma P; Sui C; Meng F; Liu Y; Jiang Y; Fang J
Eur J Pharm Biopharm; 2014 Aug; 87(3):445-53. PubMed ID: 24846793
[TBL] [Abstract][Full Text] [Related]
16. In vivo targeted delivery of nanoparticles for theranosis.
Koo H; Huh MS; Sun IC; Yuk SH; Choi K; Kim K; Kwon IC
Acc Chem Res; 2011 Oct; 44(10):1018-28. PubMed ID: 21851104
[TBL] [Abstract][Full Text] [Related]
17. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
18. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled glycol chitosan nanoparticles for disease-specific theranostics.
Yhee JY; Son S; Kim SH; Park K; Choi K; Kwon IC
J Control Release; 2014 Nov; 193():202-13. PubMed ID: 24845129
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy.
Lee SJ; Min HS; Ku SH; Son S; Kwon IC; Kim SH; Kim K
Nanomedicine (Lond); 2014 Aug; 9(11):1697-713. PubMed ID: 25321170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
